Revvity (RVTY) insider buying and selling
Every Table I transaction reported by directors and officers of S&P 500 companies on SEC Form 4 filings (2 business days to file): each row labeled with its official transaction code, nothing filtered out beforehand.
Open-market purchases (code P) are the rare signal, in green; sales (code S) are common and often pre-scheduled (10b5-1). Table II (derivatives) is not included: its prices are exercise prices, not market values. Guide: insider buying.
| Date | Ticker | Insider | Role | Shares | Price | Amount | % of stake | Type / filing |
|---|
Download these transactions as CSV No account, no sign-up. The data is public: it comes from SEC Form 4 filings.
Revvity, Inc. (RVTY) insider buying and selling: no purchases, 11 sales
53 Form 4 Table I transactions filed with the SEC by Revvity, Inc. insiders between 2025-08-28 and 2026-10-02 (15-month history): 0 open-market purchases and 11 sales, plus 42 transactions under other Form 4 codes, broken down one by one below. The largest open-market trade is a sale of $2.6M by Singh Prahlad R. on 2026-02-05.
Revvity insider buying and selling over the last 12 months
Between Oct 21, 2025 and Oct 20, 2026, Revvity insiders filed 10 sales worth $6.0M on the open market, and no purchases.
The biggest seller was Singh Prahlad R. (Please See Remarks): $2.6M in 1 sale, out of 7 different sellers.
The largest trade of the period was a sale of $2.6M on Feb 5, 2026, by Singh Prahlad R. (Please See Remarks), under a 10b5-1 plan. Form 4 on sec.gov (0001193125-26-041158).
Of the 10 sales, 9 (90%, $5.9M) carry the 10b5-1 plan flag on the Form 4, meaning they were scheduled months ahead; the other one does not.
The last three months show 3 sales, against 1 in the three before. The latest sale from Oct 1, 2026.
Against its sector (Healthcare, 59 companies with an insider page on this site), over the same dates the median is 9 sales and 0 purchases on the open market. Revvity has more sales than 31 of the other 58, ranks 39 of 59 by net dollars sold, and 19 of the 59 have at least one purchase.
The 20 most important trades
With no open-market purchases, the table starts with RVTY's sales, largest first. The full history is in the tool above, already searched.
See all 53 RVTY trades in the full history →
| Trade date | Filed | Insider | Role | Amount | Code | Filing |
|---|---|---|---|---|---|---|
| 2026-02-05 | 2026-02-06 | Singh Prahlad R. | Please See Remarks | $2.6M | S — Open-market sale (scheduled 10b5-1)6 Form 4 footnotesF4 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025. F5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.07. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F6 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.10 to $100.08. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F7 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.10 to $101.09. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F8 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $101.12 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F9 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. | SEC |
| 2026-02-05 | 2026-02-06 | Goldberg Joel S | Please See Remarks | $1.3M | S — Open-market sale (scheduled 10b5-1)5 Form 4 footnotesF4 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 6, 2025. F5 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $98.98 to $99.97. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F6 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $99.98 to $100.95. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F7 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $100.98 to $101.93. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. F8 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $102.18 to $103.03. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. | SEC |
| 2026-09-16 | 2026-09-18 | Vohra Tajinder S | Please See Remarks | $1.0M | S — Open-market sale (scheduled 10b5-1)Form 4 footnoteF1 The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 15, 2026. | SEC |
| 2026-02-02 | 2026-02-04 | Vohra Tajinder S | Please See Remarks | $602k | S — Open-market sale (scheduled 10b5-1)Form 4 footnoteF1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025. | SEC |
| 2026-09-21 | 2026-09-23 | Krakowiak Maxwell | Please See Remarks | $236k | S — Open-market sale (scheduled 10b5-1)Form 4 footnoteF1 The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on May 19, 2026. | SEC |
| 2026-02-24 | 2026-02-26 | Victor Miriame | Please See Remarks | $181k | S — Open-market sale (scheduled 10b5-1)Form 4 footnoteF1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 26, 2025. | SEC |
| 2026-02-23 | 2026-02-25 | Mcmurry-Heath Michelle | Director | $58k | S — Open-market saleForm 4 footnoteF1 The price reported represents a weighted average sale price of shares sold in multiple transactions at prices ranging from $97.15 to $97.35. The Reporting Person hereby undertakes, upon request of the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, to provide full information regarding the number of shares sold at each separate price. | SEC |
| 2025-08-27 | 2025-08-28 | Michas Alexis P | Director | $45k | S — Open-market sale Indirect holding, through: By The Cayre and Alexis Michas Foundation Corp. Form 4 footnoteF1 Securities held in a charitable foundation that was established for the sole purpose of making charitable contributions. The directors of the foundation are the Reporting Person, his spouse and their adult children. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, if any, and the filing of this report is not an admission that the Reporting Person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose. | SEC |
| 2026-10-01 | 2026-10-02 | Gonzales Anita | VP and CAO | $13k | S — Open-market sale (scheduled 10b5-1)Form 4 footnoteF1 The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. | SEC |
| 2026-07-20 | 2026-07-22 | Gonzales Anita | Vice President and CAO | $9k | S — Open-market sale (scheduled 10b5-1)Form 4 footnoteF1 The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. | SEC |
| 2026-04-20 | 2026-04-22 | Gonzales Anita | Vice President and CAO | $7k | S — Open-market sale (scheduled 10b5-1)Form 4 footnoteF1 The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 7, 2025. | SEC |
| 2026-02-05 | 2026-02-06 | Singh Prahlad R. | Please See Remarks | $2.4M | M — Option exercise (scheduled 10b5-1) | SEC |
| 2026-02-05 | 2026-02-06 | Goldberg Joel S | Please See Remarks | $1.2M | M — Option exercise (scheduled 10b5-1) | SEC |
| 2026-02-17 | 2026-02-19 | Singh Prahlad R. | Please See Remarks | $663k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 16, 2023, as required by the Reporting Person's Restricted Stock Agreement. | SEC |
| 2026-02-02 | 2026-02-04 | Vohra Tajinder S | Please See Remarks | $530k | M — Option exercise (scheduled 10b5-1)Form 4 footnoteF1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on February 20, 2025. | SEC |
| 2026-02-04 | 2026-02-06 | Singh Prahlad R. | Please See Remarks | $346k | F — Tax withholding (shares surrendered for taxes) (scheduled 10b5-1)2 Form 4 footnotesF1 The vesting schedule for the restricted stock unit grant to the Reporting Person included in the Form 4 filed on February 6, 2025 was incorrectly reported due to administrative error. The restricted stock unit grant included in that Form 4 is scheduled to vest in three equal annual installments beginning on the first anniversary of the date of grant. F2 These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 4, 2025, as required by the Reporting Person's Restricted Stock Unit Agreement. | SEC |
| 2026-02-17 | 2026-02-19 | Krakowiak Maxwell | Please See Remarks | $227k | F — Tax withholding (shares surrendered for taxes)2 Form 4 footnotesF1 These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 16, 2023, as required by the Reporting Person's Restricted Stock Agreement. F2 These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock units originally granted on February 16, 2023, as required by the Reporting Person's Restricted Stock Unit Agreement. | SEC |
| 2026-02-24 | 2026-02-26 | Victor Miriame | Please See Remarks | $178k | M — Option exercise (scheduled 10b5-1)Form 4 footnoteF1 The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on November 26, 2025. | SEC |
| 2026-02-17 | 2026-02-19 | Goldberg Joel S | Please See Remarks | $166k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 16, 2023, as required by the Reporting Person's Restricted Stock Agreement. | SEC |
| 2026-02-17 | 2026-02-19 | Victor Miriame | Please See Remarks | $99k | F — Tax withholding (shares surrendered for taxes)Form 4 footnoteF1 These shares are being surrendered to satisfy a tax withholding obligation upon vesting of restricted stock originally granted on February 16, 2023, as required by the Reporting Person's Restricted Stock Agreement. | SEC |
The period balance: money in, money out
In the Form 4 filings submitted between Aug 28, 2025 and Oct 2, 2026 there is not one open-market purchase of Revvity, Inc.: 11 sales worth $6.0M and zero dollars bought.
Only codes P and S count, where an insider puts in or takes out their own money. A selling balance like Revvity, Inc.'s is the norm in the S&P 500, where much of the pay comes as stock. It is not a recommendation to buy or sell: it is what was filed.
Every transaction, code by code
| Code | What it means | Trades | Reported amount |
|---|---|---|---|
| A | Grant or award | 16 | $0 |
| F | Tax withholding (shares surrendered for taxes) | 15 | $1.9M |
| S | Open-market sale | 11 | $6.0M |
| G | Gift | 7 | $0 |
| M | Option exercise | 4 | $4.2M |
| Total | Everything filed in the period | 53 | $12.1M |
23 of the 53 rows carry no usable amount on the Form 4: they count as trades and add $0. The code labels come from the SEC index.
Who has traded
Over the 15 months of history, 15 distinct people or entities have filed Revvity, Inc. transactions: none bought on the open market and 8 sold. Counted by CIK, the fixed number the SEC gives each filer, and not by name, which each filer types their own way.
Of the 8 who sold on the open market (11 sales in all), the three biggest sellers account for $5.5M of the $6.0M: 91% of the money in three people.
| Filer | Role | Transactions | Bought (count) | Sold (count) | Last filed |
|---|---|---|---|---|---|
| Singh Prahlad R. | Please See Remarks | 9 | — | $2.6M (1) | 2026-08-17 |
| Vohra Tajinder S | Please See Remarks | 6 | — | $1.6M (2) | 2026-09-18 |
| Goldberg Joel S | Please See Remarks | 7 | — | $1.3M (1) | 2026-08-18 |
| Krakowiak Maxwell | Please See Remarks | 5 | — | $236k (1) | 2026-09-23 |
| Victor Miriame | Please See Remarks | 5 | — | $181k (1) | 2026-02-26 |
| Mcmurry-Heath Michelle | Director | 2 | — | $58k (1) | 2026-05-11 |
| Michas Alexis P | Director | 3 | — | $45k (1) | 2026-08-25 |
| Gonzales Anita | VP and CAO | 9 | — | $30k (3) | 2026-10-02 |
Shown here are the 8 who moved the most money, out of 15. The rest are in the full history, one link above. The name links to all their trades, in any company. "Transactions" counts any code; the money, open market only. Role: from their latest filing.
Month by month
By the month the trade was executed, not the month it was filed; months with no trades show zero. The busiest month was Feb 2026: 0 purchases and 5 sales, worth $4.7M. 9 of the 15 months have none.
| Month | Purchases | Amount | Sales | Amount |
|---|---|---|---|---|
| Aug 2025 | 0 | $0 | 1 | $45k |
| Sep 2025 | 0 | $0 | 0 | $0 |
| Oct 2025 | 0 | $0 | 0 | $0 |
| Nov 2025 | 0 | $0 | 0 | $0 |
| Dec 2025 | 0 | $0 | 0 | $0 |
| Jan 2026 | 0 | $0 | 0 | $0 |
| Feb 2026 | 0 | $0 | 5 | $4.7M |
| Mar 2026 | 0 | $0 | 0 | $0 |
| Apr 2026 | 0 | $0 | 1 | $7k |
| May 2026 | 0 | $0 | 0 | $0 |
| Jun 2026 | 0 | $0 | 0 | $0 |
| Jul 2026 | 0 | $0 | 1 | $9k |
| Aug 2026 | 0 | $0 | 0 | $0 |
| Sep 2026 | 0 | $0 | 2 | $1.3M |
| Oct 2026 | 0 | $0 | 1 | $13k |
The last month may be partial: a Form 4 is filed up to two business days later. The table does not say whether the pattern is good or bad; it says when it happened.
Revvity, Inc. (RVTY) analysis page →
Other Healthcare companies with insider trades
All 500 are listed in the section index →
Which insiders are buying their own company stock →
How to read this data
9 of the 11 sales in the table are flagged as scheduled (10b5-1 plan): signed months ahead and executed automatically, so they say nothing about what the insider thinks today. Revvity has no open-market purchase (code P) in the history, the most common case in the S&P 500: insiders are already paid in stock. The latest filing is from Oct 2, 2026, and a Form 4 arrives up to two business days after the trade.
18 of the 20 rows in the table carry footnotes from the Form 4 itself, folded into the code column and copied verbatim; a row with no footnote means the filing has none.
Guide: Insider buying · all guides
What is behind these trades
The concepts on this page, explained from scratch in the Academy. Free, no account.
- What the efficiency hypothesis says and what it does NOT sayIf an insider's purchase is public and anyone can read it, is there any information left in it? That is the exact question that brings people here.
- Who really moves the market: the types of investorWho sits on the other side of each order, and where a company's own insiders fit among them.
- Supply, demand and price: why it rises and falls constantlyHow a piece of news ends up inside the price, and why the reaction to a filed sale is rarely the one you would expect.
Source: SEC EDGAR Form 4. This is a list of public facts, not financial advice or a recommendation to buy or sell.